宫外孕Ⅱ号方加味联合甲氨蝶呤治疗异位妊娠临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R714.22

基金项目:


Clinical Study on Modified Ectopic Pregnancy Prescription Ⅱ Combined with Methotrexate for Ectopic Pregnancy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察宫外孕Ⅱ号方加味联合甲氨蝶呤治疗异位妊娠的临床效果。方法:选择异位妊娠患者 84例,按随机数字表法分为观察组和对照组各42例。对照组给予甲氨蝶呤治疗,观察组在对照组基础上给予 宫外孕Ⅱ号方加味治疗,治疗2周。评价2组临床疗效,比较2组症状改善时间,检测2组治疗前后血清人绒毛 膜促性腺激素(HCG)、孕酮(P) 和妊娠相关血浆蛋白A(PAPP-A)、卵泡刺激素(FSH) 水平,运用简明生 活质量量表(SF-36) 评价2组治疗前后的生活质量,统计2组不良反应发生率。结果:观察组总有效率为 95.24%,高于对照组78.57%(P<0.05)。观察组包块消失、阴道出血停止、腹痛消失、HCG恢复至正常时间 均分别短于对照组,住院时间短于对照组(P<0.05)。治疗后,2组血清HCG、P、PAPP-A、FSH水平均较治 疗前降低(P<0.05),且观察组血清HCG、P、PAPP-A、FSH水平均低于对照组(P<0.05)。治疗后,2组躯 体功能、物质生活、社会功能、情感职能评分较治疗前升高(P<0.05),且观察组躯体功能、物质生活、社会 功能、情感职能评分均高于对照组(P<0.05)。观察组的不良反应发生率为2.38%,低于对照组16.67%(P< 0.05)。结论:宫外孕Ⅱ号方加味联合甲氨蝶呤治疗异位妊娠的效果理想,可有效缓解临床症状,调节血清激 素水平,提高患者生活质量,且安全性较好。

    Abstract:

    Abstract: Objective: To observe the clinical effect of modified Ectopic Pregnancy Prescription Ⅱ combined with methotrexate on ectopic pregnancy. Methods:A total of 84 cases of patients with ectopic pregnancy were selected and divided into the observation group and the control group according to the random number table method, with 42 cases in each group. The control group was treated with Methotrexate, and the observation group was additionally treated with modified Ectopic Pregnancy PrescriptionⅡbased on the treatment of the control group. Both groups were treated for two weeks. Clinical effects were evaluated in the two groups. The improvement time of symptoms was compared between the two groups. The levels of human chorionic gonadotropin (HCG),progesterone (P),pregnancy-associated plasma protein A (PAPP-A), and follicle-stimulating hormone (FSH) in serum were detected before and after treatment in two groups. Quality of life in the two groups was evaluated by the 36-Item Short Form Health Survey Questionnaire (SF-36) before and after treatment. The incidence of adverse reactions in the two groups was counted. Results: The total effective rate was 95.24% in the observation group, higher than that of 78.57% in the control group (P<0.05). The time of disappearance of the lump, cessation of vaginal bleeding, disappearance of abdominal pain, and recovery of HCG to normal in the observation group was shorter than that in the control group,and the hospitalization time in the observation group was shorter than that in the control group (P<0.05). After treatment,the levels of HCG,P,PAPP-A,and FSH in serum in the two groups were decreased when compared with those before treatment (P<0.05), and the levels of HCG,P,PAPP-A,and FSH in serum in the observation group were lower than those in the control group (P<0.05). After treatment, the scores of physical functioning, material life, social functioning, and emotional role in the two groups were increased when compared with those before treatment (P<0.05), and the scores of physical functioning, material life, social functioning, and emotional role in the observation group were higher than those in the control group (P<0.05). The incidence of adverse reactions was 2.38% in the observation group,lower than that of 16.67% in the control group (P<0.05). Conclusion: Modified Ectopic Pregnancy Prescription Ⅱcombined with Methotrexate has ideal effects on the treatment of ectopic pregnancy, which can effectively relieve clinical symptoms, regulate serum hormone levels,and improve quality of life with good safety.

    参考文献
    相似文献
    引证文献
引用本文

胡丽红,杨燕婷.宫外孕Ⅱ号方加味联合甲氨蝶呤治疗异位妊娠临床研究[J].新中医,2024,56(11):85-89

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-06-17
  • 出版日期:
文章二维码